TD Cowen analyst Phil Nadeau maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target of $525.00. The company’s shares closed yesterday at $438.40.

Investing.com -- TD Cowen downgraded Celsius Holdings (NASDAQ:CELH) to Hold and slashed its price target for the stock to $29 from $40 in a note Wednesday, citing slowing sales growth, intensifying ...

A curated selection of the top 10 logistics and supply chain stories from 2024, reflecting key trends and themes identified by LM Group News Editor Jeff Berman—offering insights beyond popularity ...

TD Cowen upgraded Salesforce's (NYSE:CRM) rating to Buy from Hold and raised the price target to $400 from $380. Shares of Salesforce rose about 2% on Friday. Analysts led by Derrick Wood said ...

Investing.com-- TD Cowen analysts have upgraded Salesforce Inc's (NYSE:CRM) rating and raised their price target, citing optimism over the company’s role in the expanding "Agentic AI" cycle. Analysts ...

Investing.com -- TD Cowen upgraded SAP SE ADR (NYSE:SAP) stock to Buy from Hold and raised its price target to $305 from $240. Analysts at the bank cited SAP's resilient stock appreciation and ...

Investing.com -- TD Cowen upgraded SAP SE ADR (NYSE:SAP) stock to Buy from Hold and raised its price target to $305 from $240. Analysts at the bank cited SAP's resilient stock appreciation and growth ...

Investing.com -- TD Cowen initiated coverage of ConocoPhillips (NYSE:COP) with a "Buy" rating and a $125 price target, noting its vast asset base, low-cost operations, and long-term growth drivers ...

Investing.com-- TD Cowen analysts have upgraded Salesforce Inc's (NYSE:CRM) rating and raised their price target, citing optimism over the company’s role in the expanding "Agentic AI" cycle.

TD Cowen analyst Bryan Bergin maintained a Hold rating on Paychex (PAYX – Research Report) today and set a price target of $146.00. The company’s shares closed yesterday at $146.84.